1. Home
  2. MTEX vs NKGN Comparison

MTEX vs NKGN Comparison

Compare MTEX & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEX
  • NKGN
  • Stock Information
  • Founded
  • MTEX 1993
  • NKGN 2017
  • Country
  • MTEX United States
  • NKGN United States
  • Employees
  • MTEX N/A
  • NKGN N/A
  • Industry
  • MTEX Medicinal Chemicals and Botanical Products
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MTEX Health Care
  • NKGN Health Care
  • Exchange
  • MTEX Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • MTEX 13.6M
  • NKGN 14.1M
  • IPO Year
  • MTEX 1999
  • NKGN N/A
  • Fundamental
  • Price
  • MTEX $7.47
  • NKGN $0.37
  • Analyst Decision
  • MTEX
  • NKGN
  • Analyst Count
  • MTEX 0
  • NKGN 0
  • Target Price
  • MTEX N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • MTEX 4.3K
  • NKGN 447.1K
  • Earning Date
  • MTEX 11-05-2024
  • NKGN 11-12-2024
  • Dividend Yield
  • MTEX N/A
  • NKGN N/A
  • EPS Growth
  • MTEX N/A
  • NKGN N/A
  • EPS
  • MTEX N/A
  • NKGN N/A
  • Revenue
  • MTEX $122,380,000.00
  • NKGN N/A
  • Revenue This Year
  • MTEX N/A
  • NKGN N/A
  • Revenue Next Year
  • MTEX N/A
  • NKGN N/A
  • P/E Ratio
  • MTEX N/A
  • NKGN N/A
  • Revenue Growth
  • MTEX N/A
  • NKGN N/A
  • 52 Week Low
  • MTEX $6.75
  • NKGN $0.35
  • 52 Week High
  • MTEX $10.51
  • NKGN $5.10
  • Technical
  • Relative Strength Index (RSI)
  • MTEX 49.21
  • NKGN 28.92
  • Support Level
  • MTEX $7.05
  • NKGN $0.36
  • Resistance Level
  • MTEX $7.90
  • NKGN $0.44
  • Average True Range (ATR)
  • MTEX 0.14
  • NKGN 0.04
  • MACD
  • MTEX -0.04
  • NKGN 0.01
  • Stochastic Oscillator
  • MTEX 44.68
  • NKGN 10.58

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: